1-9 of 9
David Venzon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

Free
Laleh Amiri-Kordestani, Victoria Luchenko, Cody J. Peer, Kambiz Ghafourian, James Reynolds, Deb Draper, Robin Frye, Sue Woo, David Venzon, John Wright, Monica Skarulis, William D. Figg, Tito Fojo, Susan E. Bates, Richard L. Piekarz
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (16): 4499–4507.
https://doi.org/10.1158/1078-0432.CCR-13-0095
Published: 13 August 2013
View article titled, Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
Open the PDF for Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers in another window
Includes: Supplementary data
Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors

Free
Anish Thomas, Esther Mena, Karen Kurdziel, David Venzon, Sean Khozin, Arlene W. Berman, Peter Choyke, Eva Szabo, Arun Rajan, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1487–1493.
https://doi.org/10.1158/1078-0432.CCR-12-2929
Published: 14 March 2013
View article titled, 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors
Open the PDF for 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors in another window
Includes: Supplementary data
Journal Articles

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Free
Cody J. Peer, Tristan M. Sissung, AeRang Kim, Lokesh Jain, Sukyung Woo, Erin R. Gardner, C. Tyler Kirkland, Sarah M. Troutman, Bevin C. English, Emily D. Richardson, Joel Federspiel, David Venzon, William Dahut, Elise Kohn, Shivaani Kummar, Robert Yarchoan, Giuseppe Giaccone, Brigitte Widemann, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 2099–2107.
https://doi.org/10.1158/1078-0432.CCR-11-2484
Published: 01 April 2012
View article titled, Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Open the PDF for Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia in another window
Includes: Supplementary data
Journal Articles

Impact of ABCB1 Allelic Variants on QTc Interval Prolongation

Free
Tristan M. Sissung, Erin R. Gardner, Richard L. Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo, Ryan Franke, James A. Clark, Laura Miller-DeGraff, Seth M. Steinberg, David Venzon, David Liewehr, Steven R. Kleeberger, Susan E. Bates, Douglas K. Price, Douglas R. Rosing, Christopher Cabell, Alex Sparreboom, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 937–946.
https://doi.org/10.1158/1078-0432.CCR-10-0925
Published: 15 February 2011
View article titled, Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
Open the PDF for Impact of ABCB1 Allelic Variants on QTc Interval Prolongation in another window
Includes: Supplementary data
Journal Articles

Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody

Free
Masaki Terabe, Elena Ambrosino, Shun Takaku, Jessica J. O'Konek, David Venzon, Scott Lonning, John M. McPherson, Jay A. Berzofsky
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6560–6569.
https://doi.org/10.1158/1078-0432.CCR-09-1066
Published: 02 November 2009
View article titled, Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody
Open the PDF for Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody in another window
Includes: Supplementary data
Journal Articles

Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer

Free
Akinobu Hamada, Tristan Sissung, Douglas K. Price, Romano Danesi, Cindy H. Chau, Nima Sharifi, David Venzon, Kenji Maeda, Keisuke Nagao, Alex Sparreboom, Hiroaki Mitsuya, William L. Dahut, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3312–3318.
https://doi.org/10.1158/1078-0432.CCR-07-4118
Published: 02 June 2008
View article titled, Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer
Open the PDF for Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer in another window
Journal Articles

A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy

Free
John P. Chute, Elizabeth Taylor, John Williams, Frederic Kaye, David Venzon, Bruce E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 888–896.
https://doi.org/10.1158/1078-0432.CCR-05-1536
Published: 07 February 2006
View article titled, A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy
Open the PDF for A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy in another window
Journal Articles

A Phase I Trial and Pharmacokinetic Study of Tipifarnib, a Farnesyltransferase Inhibitor, and Tamoxifen in Metastatic Breast Cancer

Free
Peter F. Lebowitz, Jennifer Eng-Wong, Brigitte C. Widemann, Frank M. Balis, Nalini Jayaprakash, Catherine Chow, Geoff Clark, Susan B. Gantz, David Venzon, JoAnne Zujewski
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1247–1252.
https://doi.org/10.1158/1078-0432.1247.11.3
Published: 11 February 2005
View article titled, A Phase I Trial and Pharmacokinetic Study of Tipifarnib, a Farnesyltransferase Inhibitor, and Tamoxifen in Metastatic Breast Cancer
Open the PDF for A Phase I Trial and Pharmacokinetic Study of Tipifarnib, a Farnesyltransferase Inhibitor, and Tamoxifen in Metastatic Breast Cancer in another window
Journal Articles

A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer

Free
Peter F. Lebowitz, Jennifer Eng-Wong, Sandra M. Swain, Arlene Berman, Maria J. Merino, Catherine K. Chow, David Venzon, Farah Zia, David Danforth, Edison Liu, JoAnne Zujewski
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6764–6769.
https://doi.org/10.1158/1078-0432.CCR-04-0976
Published: 22 October 2004
View article titled, A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer
Open the PDF for A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer in another window